The global life science instrumentation market in terms of revenue was estimated to be worth $54.9 billion in 2023 and is poised to reach $73.9 billion by 2028, growing at a CAGR of 6.1% from 2023 to 2028. The key player operating in the global life science instrumentation market are Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Agilent Technologies, Inc. (US), Waters Corporation (US), Shimadzu Corporation (Japan), Becton, Dickinson and Company (US), PerkinElmer Inc. (US), Bio-Rad Laboratories, Inc. (US), Bruker (US), and Hitachi High-Technologies Corporation (Japan). Download the PDF Brochure at https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=38&utm_source=Ganesh&utm_medium=P #lifescienceinstrumentationmarket #lifescienceinstrumentationmarketsize #lifescienceinstrumentationmarketgrowth #lifescienceinstrumentationmarkettrends